Phase II non-randomised interventional treatment study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Carboplatin; Cisplatin; Paclitaxel
- Indications Cervical cancer
- Focus Therapeutic Use
- Acronyms CxII
- 26 Aug 2013 Biomarkers information updated
- 01 May 2010 New source identified and integrated (ISRCTN: Current Controlled Trials record no. 98873899).
- 01 May 2010 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.